| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| BELANOFF JOSEPH K | Chief Executive Officer, Director | C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY | /s/ Joseph Douglas Lyon, as attorney-in-fact for Joseph K. Belanoff. | 04 Jun 2025 | 0001286199 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CORT | Common Stock | Sale | $382,773 | -4,881 | -0.17% | $78.42 | 2,937,104 | 02 Jun 2025 | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 | F1, F2, F3 |
| transaction | CORT | Common Stock | Sale | $242,421 | -3,050 | -0.1% | $79.48 | 2,934,054 | 02 Jun 2025 | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 | F1, F3, F4 |
| transaction | CORT | Common Stock | Sale | $239,941 | -2,988 | -0.1% | $80.30 | 2,931,066 | 02 Jun 2025 | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 | F1, F3, F5 |
| transaction | CORT | Common Stock | Sale | $148,012 | -1,820 | -0.06% | $81.33 | 2,929,246 | 02 Jun 2025 | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 | F1, F3, F6 |
| transaction | CORT | Common Stock | Sale | $103,899 | -1,263 | -0.04% | $82.26 | 2,927,983 | 02 Jun 2025 | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 | F1, F3, F7 |
| transaction | CORT | Common Stock | Sale | $386,523 | -4,631 | -0.16% | $83.46 | 2,923,352 | 02 Jun 2025 | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 | F1, F3, F8 |
| transaction | CORT | Common Stock | Sale | $1,095,962 | -12,959 | -0.44% | $84.57 | 2,910,393 | 02 Jun 2025 | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 | F1, F3, F9 |
| transaction | CORT | Common Stock | Sale | $714,778 | -8,408 | -0.29% | $85.01 | 2,901,985 | 02 Jun 2025 | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 | F1, F3, F10 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction. |
| F2 | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $77.84 to $78.83 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| F3 | Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein. |
| F4 | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $78.88 to $79.865 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| F5 | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $79.90 to $80.8925 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| F6 | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $80.92 to $81.78 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| F7 | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $81.935 to $82.80 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| F8 | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $82.96 to $83.95 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| F9 | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $83.975 to $84.94 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
| F10 | Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $85.00 to $85.31 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |
The power of attorney under which this form was signed is on file with the Commission.